Insidermedicine Daily News (Video)
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.
Show all Visit Show Website http://www.insidermedicine.caRecently Aired
-
HD
Anxiety raises risk of stroke
(December 24, 2013 - Insidermedicine) From Pittsburgh - A new ...
(December 24, 2013 - Insidermedicine) From Pittsburgh - A new report published in Stroke finds that anxiety raises risk of stroke. Researchers followed a nationally representative group of over 6,000 individuals. Participants were between 25-74 years old and were followed for 22 years. Results showed that those in the highest third of anxiety symptoms were at 33% increased risk of stroke when compared to those with the lowest levels.
-
HD
Heart disease linked to dementia in older women
(December 23, 2013 - Insidermedicine) From Germany - A new ...
(December 23, 2013 - Insidermedicine) From Germany - A new report published in the Journal of the American Heart Association finds that heart disease may be linked to dementia in older women. researchers conducted neurocognitive exams on nearly 6,500 postmenopausal women aged 65-79. Participants had healthy brain functioning at the outset of the study. Results shooed that those with heart disease or vascular disease were at 29% increased risk of experience cognitive decline over time, when compared to those without heart disease.
-
HD
Individuals with metabolic syndrome have lower tear volume
(December 20, 2013 - Insidermedicine) From Japan - Individuals with ...
(December 20, 2013 - Insidermedicine) From Japan - Individuals with metabolic syndrome have decreased tear volume, according to a report published in the British Journal of Ophthalmology. Researchers studied nearly 700 individuals aged 26-64. Participants were evaluated for metabolic syndrome and had their tear volume measured using the Schirmer 1 method. Results showed that individuals with metabolic syndrome had significantly lower tear secretion that those without the condition, or those with pre-metabolic syndrome.
-
HD
Tomato rich diet may lower risk of breast cancer
(December 20, 2013 - Insidermedicine) From New Jersey - According ...
(December 20, 2013 - Insidermedicine) From New Jersey - According to research published in the Journal of Clinical Endocrinology & Metabolism, a diet high in tomatoes may reduce risk of breast cancer. Researchers studied a group of post-menopausal women, having participants consume 25 milligrams of lycopene a day for 10 straight weeks. For an additional 10 weeks, participants consumed 40 g of soy protein a day. Results showed that participants experienced improvements in a blood sugar and fat regulation following the tomato-rich diet--an aspect that may help post-menopausal women reduce their risk of breast cancer.
-
HD
Report examines Metformin for childhood obesity
(December 18, 2013 - Insidermedicine) From Oregon - A new ...
(December 18, 2013 - Insidermedicine) From Oregon - A new report published in JAMA Pediatrics examines the use of metformin for childhood obesity. Researchers conducted a meta-analysis of 14 clinical trials, comprised of nearly 1,000 children and adolescents from 10-16 years of age. Participants had a BMI of 26-41. Results showed that though metformin heaped reduce BMI in obese children, the change was too modest--not even reaching a 5% reduction in BMI.
-
HD
Apple a day may reduce risk of vascular death
(December 17, 2013 - Insidermedicine) From the UK - An ...
(December 17, 2013 - Insidermedicine) From the UK - An apple a day may actually keep the doctor away, according to a report published in the BMJ. Researchers conducted mathematical modelling, analyzing the effect that prescribing a statin a day or an apple a day would have on vascular mortality. Results showed that offering daily statins to 17 million more adults could reduce vascular deaths by 9,400 a year, while offering a daily apple to 70% of the UK population over the age of 50 could lower annual vascular deaths by 8,500.
-
HD
Heavy marijuana use linked to brain changes
(December 17, 2013 - Insidermedicine) From Chicago - A new ...
(December 17, 2013 - Insidermedicine) From Chicago - A new report published in Schizophrenia Bulletin finds that heavy marijuana use may change brain structure and memory. Researchers studied nearly 100 individuals between 16 and 17 years of age and followed them for 3 years. Participants either had a history of marijuana use disorders, schizophrenia with no substance abuse disorders, schizophrenia with substance abuse disorders, or were healthy controls. All participants were marijuana free for two years prior to onset of the study. Results showed those who were heavy marijuana users had abnormalities in the brain structures related to working memory.
-
HD
Aspartame is safe
(December 16, 2013 - Insidermedicine) From the UK - Aspartame ...
(December 16, 2013 - Insidermedicine) From the UK - Aspartame is safe, according to a report released by the European Food Safety Authority. Researchers conduced a meta-analysis on all available studies examining aspartame. These studies included both human and animal studies. They found that, with current levels of daily intake, aspartame is not linked to genetic damage or cancer. As well, aspartame was not found to affect cognitive function.
-
HD
Anastrozole may cut breast cancer risk in half among those at high risk
(December 16, 2013 - Insidermedicine) From London - According to ...
(December 16, 2013 - Insidermedicine) From London - According to research published in the Lancet, the drug anastrozole may cut risk of breast cancer in high risk women by 50%. Researchers studied nearly 4,000 postmenopausal women who were at high risk of breast cancer. Participants were randomized to either daily anastrozole or placebo and were followed for five years. Results showed that daily anastrozole reduced risk of developing breast cancer by 53%.
-
HD
Two thirds of elderly need assistance from devices or people to go about daily lives
(December 12, 2013 - Insidermedicine) From Michigan - A new ...
(December 12, 2013 - Insidermedicine) From Michigan - A new report published in the American Journal of Public Health finds a majority of elderly Americans need a device or help from another person to help them in their daily lives. Researchers studied data on a nationally representative sample of over 8,000 men and women over the age of 65. Results showed that two-thirds of these individuals required assistance from a device or a person to help them go about their daily activities.
